Consort Medical plc (LON:CSRT) insider Paul Hayes acquired 14 shares of the company’s stock in a transaction that occurred on Tuesday, November 7th. The stock was acquired at an average cost of GBX 1,079 ($14.19) per share, for a total transaction of £151.06 ($198.68).
Paul Hayes also recently made the following trade(s):
- On Monday, October 9th, Paul Hayes acquired 14 shares of Consort Medical plc stock. The stock was acquired at an average cost of GBX 1,088 ($14.31) per share, for a total transaction of £152.32 ($200.34).
- On Thursday, September 7th, Paul Hayes acquired 14 shares of Consort Medical plc stock. The stock was acquired at an average cost of GBX 1,088 ($14.31) per share, for a total transaction of £152.32 ($200.34).
Consort Medical plc (LON CSRT) opened at GBX 1,115.40 ($14.67) on Friday. Consort Medical plc has a 1-year low of GBX 960 ($12.63) and a 1-year high of GBX 1,129 ($14.85).
WARNING: “Consort Medical plc (CSRT) Insider Buys £151.06 in Stock” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/11/12/consort-medical-plc-csrt-insider-buys-151-06-in-stock.html.
Separately, Stifel Nicolaus reissued a “buy” rating and issued a GBX 1,250 ($16.44) price objective on shares of Consort Medical plc in a report on Thursday. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of GBX 1,178.17 ($15.50).
Consort Medical plc Company Profile
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.
Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.